Yasushi Sasaki

Prof. Dr. Yasushi Sasaki

Biology Division, Department of Liberal Arts and Sciences, Center for Medical Education, Sapporo Medical University, Sapporo 060-8556, Japan
orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2008 in Cancer Research
Verified
Journal Article
Closed access
PDF file
MTMinoru Toyota
Minoru Toyota
HSHiromu Suzuki
Hiromu Suzuki
Yasushi SasakiYasushi Sasaki
Yasushi Sasaki
RMReo Maruyama
Reo Maruyama
KIKohzoh Imai
Kohzoh Imai
TTTakashi Tokino
Takashi Tokino
Altered expression of microRNA (miRNA) is strongly implicated in cancer, and recent studies have shown that, in cancer, expression of some miRNAs cells is silenced in association with CpG island hypermethylation. To identify epigenetically silenced miRNAs in colorectal cancer (CRC), we screened for miRNAs induced in CRC cells by 5-aza-2′-deoxycytidine (DAC) treatment or DNA methyltransferase knockout. We found that miRNA-34b (miR-34b) and miR-34c, two components of the p53 network, are epigenetically silenced in CRC; that this down-regulation of miR-34b/c is associated with hypermethylation of the neighboring CpG island; and that DAC treatment rapidly restores miR-34b/c expression. Methylation of the miR-34b/c CpG island was frequently observed in CRC cell lines (nine of nine, 100%) and in primary CRC tumors (101 of 111, 90%), but not in normal colonic mucosa. Transfection of precursor miR-34b or miR-34c into CRC cells induced dramatic changes in the gene expression profile, and there was significant overlap between the genes down-regulated by miR-34b/c and those down-regulated by DAC. We also found that the miR-34b/c CpG island is a bidirectional promoter which drives expression of both miR-34b/c and B-cell translocation gene 4 (BTG4); that methylation of the CpG island is also associated with transcriptional silencing of BTG4; and that ectopic expression of BTG4 suppresses colony formation by CRC cells. Our results suggest that miR-34b/c and BTG4 are novel tumor suppressors in CRC and that the miR-34b/c CpG island, which bidirectionally regulates miR-34b/c and BTG4, is a frequent target of epigenetic silencing in CRC. [Cancer Res 2008;68(11):4123–32]

3 November 2006 in Cancer Science
Verified
Journal Article
Open access
PDF file
KAKimishige Akino
Kimishige Akino
MTMinoru Toyota
Minoru Toyota
HSHiromu Suzuki
Hiromu Suzuki
TITakashi Imai
Takashi Imai
RMReo Maruyama
Reo Maruyama
TTTakashi Tokino
Takashi Tokino
Epigenetic gene inactivation plays a key role in the development of various types of cancer. Using methylated CpG island amplification coupled with representational difference analysis to identify genes inactivated by DNA methylation in gastric cancer, we identified seven DNA fragments corresponding to the 5′ CpG islands of the affected genes. One of the clones recovered was identical to the 5′ flanking region of DFNA5, a gene previously shown to be associated with deafness and induced by DNA damage. Further analysis revealed that DFNA5 is expressed in normal tissues but is downregulated in gastric cancer cell lines due to methylation of the region around its transcription start site. Treating gastric cancer cells that lacked DFNA5 expression with a methyltransferase inhibitor, 5‐aza‐2′‐deoxycytidine, restored the gene's expression. Methylation of DFNA5 was detected in 50% of primary gastric tumors, and was correlated with positivity for Epstein–Barr virus and the absence of metastasis. Moreover, introduction of exogenous DFNA5 into silenced cells suppressed colony formation. Taken together, these data suggest that the silencing of DFNA5 occurs frequently in gastric cancer and may play a key role in development and progression of the disease. (Cancer Sci 2007; 98: 88–95)

5 February 2007 in Oncogene
Verified
Journal Article
Open access
PDF file
MNM Nojima
M Nojima
HSHiromu Suzuki
Hiromu Suzuki
MTM Toyota
M Toyota
YWY Watanabe
Y Watanabe
RMR Maruyama
R Maruyama
YSY Shinomura
Y Shinomura
Activation of Wnt signaling has been implicated in gastric tumorigenesis, although mutations in APC (adenomatous polyposis coli), CTNNB1 (β-catenin) and AXIN are seen much less frequently in gastric cancer (GC) than in colorectal cancer. In the present study, we investigated the relationship between activation of Wnt signaling and changes in the expression of secreted frizzled-related protein (SFRP) family genes in GC. We frequently observed nuclear β-catenin accumulation (13/15; 87%) and detected the active form of β-catenin in most (12/16; 75%) GC cell lines. CpG methylation-dependent silencing of SFRP1, SFRP2 and SFRP5 was frequently seen among GC cell lines (SFRP1, 16/16, 100%; SFRP2, 16/16, 100%; SFRP5, 13/16, 81%) and primary GC specimens (SFRP1, 42/46, 91%; SFRP2, 44/46, 96%; SFRP5, 30/46, 65%), and treatment with the DNA methyltransferase inhibitor 5-aza-2′-deoxycytidine rapidly restored SFRP expression. Ectopic expression of SFRPs downregulated T-cell factor/lymphocyte enhancer factor transcriptional activity, suppressed cell growth and induced apoptosis in GC cells. Analysis of global expression revealed that overexpression of SFRP2 repressed Wnt target genes and induced changes in the expression of numerous genes related to proliferation, growth and apoptosis in GC cells. It thus appears that aberrant SFRP methylation is one of the major mechanisms by which Wnt signaling is activated in GC.

3 August 2007 in Carcinogenesis
Verified
Journal Article
Open access
PDF file
HSHironobu Sato
Hironobu Sato
HSHiromu Suzuki
Hiromu Suzuki
MTMinoru Toyota
Minoru Toyota
MNMasanori Nojima
Masanori Nojima
RMReo Maruyama
Reo Maruyama
YSYasuhisa Shinomura
Yasuhisa Shinomura
Activation of Wnt signaling has been implicated in tumorigenesis, and epigenetic silencing of Wnt antagonist genes has been detected in various cancers. In the present study, we examined the expression and methylation of DICKKOPF ( DKK ) family genes in gastrointestinal cancer cell lines. We found that all known DKK genes were frequently silenced in colorectal cancer (CRC) cells ( DKK1 , 3/9, 33%; DKK2 , 8/9, 89%; DKK3 , 5/9, 56% and DKK4 , 5/9, 56%), but not in normal colon mucosa. DKK1 , - 2 and - 3 have 5′ CpG islands, and show an inverse relation between expression and methylation. DKK methylation also was frequently observed in gastric cancer (GC) cell lines ( DKK1 , 6/16, 38%; DKK2 , 15/16, 94% and DKK3 , 10/16, 63%), but was seen less frequently in hepatocellular carcinoma and pancreatic cancer cell lines. DKK s also were frequently methylated in primary CRCs ( DKK1 , 7/58, 12%; DKK2 , 45/58, 78% and DKK3 , 12/58, 21%) and GCs ( DKK1 , 15/31, 48%; DKK2 , 26/31, 84% and DKK3 , 12/31, 39%). Against a background of CTNNB1 or APC mutations, Dickkopfs (Dkks) were less effective inhibitors of Wnt signaling than secreted frizzled-related proteins, though over-expression of Dkks suppressed colony formation of CRC cells with such mutations. Our results demonstrate that DKK s are frequent targets of epigenetic silencing in gastrointestinal tumors, and that loss of DKK s may facilitate tumorigenesis through β-catenin/T-cell factor-independent mechanisms.

16 June 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MTMinoru Toyota
Minoru Toyota
Yasushi SasakiYasushi Sasaki
Yasushi Sasaki
ASAyumi Satoh
Ayumi Satoh
KOKazuhiro Ogi
Kazuhiro Ogi
TKTakefumi Kikuchi
Takefumi Kikuchi
Takashi TokinoTakashi Tokino
Takashi Tokino
Cell-cycle checkpoints controlling the orderly progression through mitosis are frequently disrupted in human cancers. One such checkpoint, entry into metaphase, is regulated by the CHFR gene encoding a protein possessing forkhead-associated and RING finger domains as well as ubiquitin–ligase activity. Although defects in this checkpoint have been described, the molecular basis and prevalence of CHFR inactivation in human tumors are still not fully understood. To address this question, we analyzed the pattern of CHFR expression in a number of human cancer cell lines and primary tumors. We found CpG methylation-dependent silencing of CHFR expression in 45% of cancer cell lines, 40% of primary colorectal cancers, 53% of colorectal adenomas, and 30% of primary head and neck cancers. Expression of CHFR was precisely correlated with both CpG methylation and deacetylation of histones H3 and H4 in the CpG-rich regulatory region. Moreover, CpG methylation and thus silencing of CHFR depended on the activities of two DNA methyltransferases, DNMT1 and DNMT3b, as their genetic inactivation restored CHFR expression. Finally, cells with CHFR methylation had an intrinsically high mitotic index when treated with microtubule inhibitor. This means that cells in which CHFR was epigenetically inactivated constitute loss-of-function alleles for mitotic checkpoint control. Taken together, these findings shed light on a pathway by which mitotic checkpoint is bypassed in cancer cells and suggest that inactivation of checkpoint genes is much more widespread than previously suspected.

1 January 2002 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
Yasushi SasakiYasushi Sasaki
Yasushi Sasaki
SISetsuko Ishida
Setsuko Ishida
IMIchiro Morimoto
Ichiro Morimoto
TYToshiharu Yamashita
Toshiharu Yamashita
TKTakashi Kojima
Takashi Kojima
TTTakashi Tokino
Takashi Tokino
The p53 tumor suppressor is a transcription factor that regulates cell growth and death in response to environmental stimuli such as DNA damage. p63/p51 andp73 were recently identified as members of the p53gene family. In contrast to p53 however, p63and p73 are rarely mutated in human cancers. Mice that lack p53 are developmentally normal, while p63 and p73 appear to play critical roles in normal development. To determine how p63 and p73 are involved in normal development, we attempted to identify target genes that are specifically regulated by p63 and/or p73 but not by p53. We found that the Jagged1 (JAG1) andJagged2 (JAG2) genes, encoding ligands for the Notch receptors, are up-regulated by p63 and p73. Furthermore, we identified a p63-binding site in the second intron of the JAG1gene, which can directly interact with the p63 protein in vivo, as assessed by a chromatin immunoprecipitation assay. A heterologous reporter assay revealed that this p63-binding site is a functional response element and is specific for p63. We also found a target of Notch signaling, HES-1 was up-regulated in Jurkat cells, in which Notch1 is highly expressed, when co-cultured with p63-transfected cells, suggesting that p63 can trigger the Notch signal pathway in neighboring cells. Our findings show an association between the p53 family genes and Notch signaling and suggest a potential molecular mechanism for the involvement of the p53family genes in normal development.